Bimi International Medical Inc
NASDAQ:BIMI
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.0001
0.034
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Bimi International Medical Inc
BIMI International Medical, Inc. engages in the provision of healthcare products. The company is headquartered in Shenyang, Liaoning. The company went IPO on 2010-10-04. The firm mainly conducts its businesses through four segments. The Wholesale Pharmaceutical segment provides prescription and over the counter (OTC) medicines, traditional Chinese medicine (TCM), healthcare supplies and sundry items to clinics, third party pharmacies, hospitals and other drug wholesalers. The Wholesale Medical Device segment distributes medical devices, including medical consumables to private clinics, hospitals, third party pharmacies and other medical device dealers. The Medical Service segment include private comprehensive hospitals operating in China. The Retail Pharmacy segment sells prescription and OTC medicines, TCM, healthcare supplies and sundry items to retail customers.
BIMI International Medical, Inc. engages in the provision of healthcare products. The company is headquartered in Shenyang, Liaoning. The company went IPO on 2010-10-04. The firm mainly conducts its businesses through four segments. The Wholesale Pharmaceutical segment provides prescription and over the counter (OTC) medicines, traditional Chinese medicine (TCM), healthcare supplies and sundry items to clinics, third party pharmacies, hospitals and other drug wholesalers. The Wholesale Medical Device segment distributes medical devices, including medical consumables to private clinics, hospitals, third party pharmacies and other medical device dealers. The Medical Service segment include private comprehensive hospitals operating in China. The Retail Pharmacy segment sells prescription and OTC medicines, TCM, healthcare supplies and sundry items to retail customers.